Arcuro Medical Secures FDA Clearance for SuperBall RC
Arcuro Medical Ltd. announced its significant achievement of obtaining FDA 510(k) clearance for the innovative SuperBall-RC™ system, a breakthrough in rotator cuff repair technology. This development marks a pivotal moment for the medical community as it aims to improve patient outcomes during rotator cuff surgeries.
Understanding the Impact of Rotator Cuff Injuries
Rotator cuff injuries are prevalent, particularly in individuals over 50, leading to re-tear rates between 20% to 40% post-surgery. This presents a substantial challenge for surgeons, who often seek effective solutions to enhance repair success rates. The SuperBall RC product offers a promising answer by leveraging advanced technology initially proven in meniscus repairs, where it has already been effectively used in over 5,000 cases.
Expert Insights on the SuperBall RC
Dr. Philip Davidson, the Medical Director at Arcuro, highlighted the device's efficiency, stating, "The SuperBall-RC has been designed to facilitate safe and easy fixation of rotator cuff augmentation grafts." His feedback emphasizes the device's potential to offer reliable alternatives for surgeons, thereby enhancing patient recovery.
A Note from Leadership
Jamal Rushdy, the CEO of Arcuro Medical, expressed his excitement about the FDA clearance, stating, "We are thrilled to have received this regulatory clearance, and I congratulate our product development and regulatory teams for their excellent work on this important milestone for the company." This achievement not only demonstrates the commitment of the team but also heralds better surgical outcomes for patients.
Future Availability of the SuperBall RC
The SuperBall-RC system is poised for a limited user release in the second quarter, followed by a full launch anticipated in the latter half of the year. This timely clearance highlights Arcuro's dedication to providing cutting-edge solutions in the medical field efficiently.
Upcoming Conferences and Presentations
Arcuro Medical is set to provide further insights into their advancements at the Canaccord Genuity Musculoskeletal Conference and the LSI Emerging MedTech Summit this year. These platforms will allow the company to connect with healthcare professionals and showcase the potential of their innovative technologies.
About Arcuro Medical Ltd.
Founded by a team of experts with extensive experience in developing and marketing minimally invasive orthopedic solutions, Arcuro Medical is focused on revolutionizing surgical practices. As a portfolio company of The Trendlines Group (SGX: 42T), Arcuro is committed to expanding its distribution networks globally while delivering innovative products, such as the SuperBall™ technology, that enhance patient care.
Contact Details
For inquiries regarding the SuperBall RC or to learn more about Arcuro Medical's other offerings, interested parties can contact:
Jamal Rushdy
Chief Executive Officer
jamal.rushdy@arcuromedical.com
Frequently Asked Questions
What is the SuperBall RC?
The SuperBall RC is an innovative system designed for rotator cuff repair that has received FDA 510(k) clearance, ensuring its safety and efficacy.
Who developed the SuperBall technology?
SuperBall technology was developed by Arcuro Medical Ltd., which specializes in minimally invasive orthopedic products.
What are the anticipated benefits of using the SuperBall RC?
This device aims to reduce re-tear rates in rotator cuff surgeries and improve fixation of augmentation grafts, benefiting patient recovery.
When will the SuperBall RC be available?
The SuperBall RC will undergo a limited user release in the second quarter, with a wider launch expected in the second half of the year.
How can I learn more about Arcuro Medical's products?
For more information, visit Arcuro Medical's official website or contact them directly through their provided email.
